HH
VRTX icon

Hilltop Holdings’s Vertex Pharmaceuticals VRTX Stock Holding History

Hilltop Holdings’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$300K Sell
671
-2,344
-78% -$1.09M 0.03% 516
2025
Q4 		$1.37M Sell
3,015
-1,919
-39% -$827K 0.08% 270
2025
Q3 		$1.93M Buy
4,934
+757
+18% +$316K 0.1% 219
2025
Q2 		$1.86M Buy
4,177
+542
+15% +$250K 0.12% 200
2025
Q1 		$1.76M Buy
3,635
+90
+3% +$41.9K 0.11% 198
2024
Q4 		$1.43M Buy
3,545
+402
+13% +$186K 0.09% 240
2024
Q3 		$1.46M Buy
3,143
+2,459
+360% +$1.18M 0.09% 234
2024
Q2 		$321K Hold
684
– – 0.04% 459
2024
Q1 		$286K Buy
684
+2
+0.3% +$845 0.03% 516
2023
Q4 		$277K Sell
682
-10
-1% -$3.69K 0.03% 485
2023
Q3 		$241K Sell
692
-11
-2% -$3.85K 0.03% 502
2023
Q2 		$247K Sell
703
-7
-1% -$2.36K 0.03% 481
2023
Q1 		$224K Sell
710
-2
-0.3% -$600 0.03% 476
2022
Q4 		$206K Hold
712
– – 0.03% 490
2022
Q3 		$206K Buy
+712
New +$205K 0.03% 468
2021
Q2 		– Sell
-1,509
Closed -$324K – 591
2021
Q1 		$324K Buy
+1,509
New +$331K 0.04% 386
2020
Q3 		– Sell
-757
Closed -$220K – 452
2020
Q2 		$220K Buy
+757
New +$205K 0.04% 351
2018
Q4 		– Sell
-1,534
Closed -$296K – 423
2018
Q3 		$296K Buy
+1,534
New +$273K 0.06% 321

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Hilltop Holdings's VRTX Position: Q1 2026 in Review

Hilltop Holdings reduced its Vertex Pharmaceuticals (VRTX) stake by 78% in Q1 2026, selling an estimated $1.09M and leaving 671 shares worth $300K. The position accounts for 0.03% of the portfolio, ranked #516.

Hilltop Holdings first reported a position in VRTX in Q3 2018 and has held it in 18 quarters since. The position peaked at $1.93M in Q3 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Hilltop Holdings held 671 shares of Vertex Pharmaceuticals worth $300K as of Q1 2026.
  • Hilltop Holdings sold 2,344 Vertex Pharmaceuticals shares in Q1 2026, an estimated $1.09M.
  • Vertex Pharmaceuticals made up 0.03% of Hilltop Holdings's portfolio in Q1 2026, its #516 holding.
  • Hilltop Holdings first reported a position in Vertex Pharmaceuticals in Q3 2018 and has held it in 18 quarters since.
  • Hilltop Holdings's Vertex Pharmaceuticals position peaked at $1.93M in Q3 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Hilltop Holdings's 13F filing for Q1 2026, filed 14 May 2026.